114 related articles for article (PubMed ID: 3095392)
21. Hydroxyethyl starch macromolecule and superoxide dismutase effects on myocardial reperfusion injury.
Oz MC; Zikria BA; McLeod PF; Popilkis SJ
Am J Surg; 1991 Jul; 162(1):59-62. PubMed ID: 1712154
[TBL] [Abstract][Full Text] [Related]
22. Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty?
Bell MR; Nishimura RA; Holmes DR; Bailey KR; Schwartz RS; Vlietstra RE
J Am Coll Cardiol; 1990 Oct; 16(4):959-66. PubMed ID: 2212378
[TBL] [Abstract][Full Text] [Related]
23. Detection of acute myocardial infarction in closed-chest dogs by analysis of regional two-dimensional echocardiographic gray-level distributions.
Skorton DJ; Melton HE; Pandian NG; Nichols J; Koyanagi S; Marcus ML; Collins SM; Kerber RE
Circ Res; 1983 Jan; 52(1):36-44. PubMed ID: 6848208
[TBL] [Abstract][Full Text] [Related]
24. Early differentiation of infarcted and noninfarcted reperfused myocardium in dogs by quantitative analysis of regional myocardial echo amplitudes.
Haendchen RV; Ong K; Fishbein MC; Zwehl W; Meerbaum S; Corday E
Circ Res; 1985 Nov; 57(5):718-28. PubMed ID: 4053305
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of Fluosol-DA in acute cerebral ischemia.
Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
[TBL] [Abstract][Full Text] [Related]
26. A comparison of lactated ringer's solution to hydroxyethyl starch 6% in a model of severe hemorrhagic shock and continuous bleeding in dogs.
Friedman Z; Berkenstadt H; Preisman S; Perel A
Anesth Analg; 2003 Jan; 96(1):39-45, table of contents. PubMed ID: 12505920
[TBL] [Abstract][Full Text] [Related]
27. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
Acar C; Partington MT; Buckberg GD
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing viable from infarcted myocardium after experimental ischemia and reperfusion by using nuclear magnetic resonance imaging.
Ryan T; Tarver RD; Duerk JL; Sawada SG; Hollenkamp NC
J Am Coll Cardiol; 1990 May; 15(6):1355-64. PubMed ID: 2329239
[TBL] [Abstract][Full Text] [Related]
29. Experimental evaluation of the extent of myocardial dyssynergy and infarct size by two-dimensional echocardiography.
Wyatt HL; Meerbaum S; Heng MK; Rit J; Gueret P; Corday E
Circulation; 1981 Mar; 63(3):607-14. PubMed ID: 7460247
[TBL] [Abstract][Full Text] [Related]
30. Effect of Fluosol-DA and hetastarch on local cerebral blood flow, cortical O2 availability and computerized EEG data during cerebral ischaemia.
Tranmer BI; Iacobacci R; Feiler S
Neurol Res; 1990 Mar; 12(1):17-22. PubMed ID: 1692110
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol-DA.
Rice HE; Virmani R; Hart CL; Kolodgie FD; Farb A
Am Heart J; 1990 Nov; 120(5):1039-46. PubMed ID: 2239656
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of stunned and infarcted canine myocardium by real time myocardial contrast echocardiography.
Dourado PM; Tsutsui JM; Mathias W; Andrade JL; da Luz PL; Chagas AC
Braz J Med Biol Res; 2003 Nov; 36(11):1501-9. PubMed ID: 14576906
[TBL] [Abstract][Full Text] [Related]
33. Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion.
Virmani R; Kolodgie FD; Osmialowski A; Zimmerman P; Mergner W; Forman MB
Am Heart J; 1988 Aug; 116(2 Pt 1):421-31. PubMed ID: 2969667
[TBL] [Abstract][Full Text] [Related]
34. Assessment of location and size of myocardial infarction with contrast-enhanced echocardiography. II. Application of digital imaging techniques.
Armstrong WF; West SR; Dillon JC; Feigenbaum H
J Am Coll Cardiol; 1984 Jul; 4(1):141-8. PubMed ID: 6376592
[TBL] [Abstract][Full Text] [Related]
35. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
Hall JE; Ehrhart IC; Hofman WF
J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806
[TBL] [Abstract][Full Text] [Related]
36. Perfluorochemicals as liver- and spleen-seeking ultrasound contrast agents.
Mattrey RF; Leopold GR; vanSonnenberg E; Gosink BB; Scheible FW; Long DM
J Ultrasound Med; 1983 Apr; 2(4):173-6. PubMed ID: 6854723
[TBL] [Abstract][Full Text] [Related]
37. Validation of three-dimensional echocardiography for quantifying the extent of dyssynergy in canine acute myocardial infarction: comparison with two-dimensional echocardiography.
Sapin PM; Clarke GB; Gopal AS; Smith MD; King DL
J Am Coll Cardiol; 1996 Jun; 27(7):1761-70. PubMed ID: 8636566
[TBL] [Abstract][Full Text] [Related]
38. Ultrasonic tissue characterization of acute canine myocardial infarction.
Tak T; Lin SL; Gamage N; Mahler C; Steen SN; Colletti P; Rahimtoola SH; Chandraratna PA
Can J Cardiol; 1989 May; 5(4):195-200. PubMed ID: 2471580
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
Hoshino S; Iwaya F; Igari T; Kanno M; Honda K
J Cardiovasc Surg (Torino); 1982; 23(6):463-9. PubMed ID: 7153234
[TBL] [Abstract][Full Text] [Related]
40. Fluosol-DA: an artificial blood for total cardiopulmonary bypass.
Engelman RM; Rousou JH; Dobbs WA
Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
